(PharmaNewsWire.Com, September 04, 2017 ) Europe Varicose Vein Treatment Market was worth USD 84.27 million in 2016 and estimated to be growing at a CAGR of 6.3%, to reach USD 114.37 million by 2021. The varicose vein treatment market is mainly driven by the rising cases of varicose veins. This condition of enlarged veins appears mostly in feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders and high blood pressure.
The market is majorly driven by bettering patient compliance owing to the advent of durable and safe techniques to address the huge burden of varicose vein incidences and the increased access to varicose vein medical devices. In addition, the healthcare industry has experienced a new trend of removing or destroying the surface veins with enhanced patient experience. However, dearth of trained vascular surgeons and high cost of varicose vein treatment procedures can hinder the growth of this market. Moreover, inconsistent reimbursement scenario limiting the adoption of endovenous ablation procedures and sustainability of players in highly competitive market are further hampering the growth of this market to a certain extent.
This report broadly segments the varicose vein treatment market into mode of treatment and products. On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the varicose vein treatment market, by mode of treatment. Based on type of products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment. On the basis of geography, the market is analysed under various regions- Italy, France, U.K , Germany and Spain. European market is expected to grow at a steady rate.
The major players in the varicose vein treatment market are Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.)
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
